InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Quirk Gerald E. Director active across 1 company, notably Syros Pharmaceuticals, Inc.. Aggregated, 4 disclosures have been logged. Breakdown: 0 buy · 1 sell. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Quirk Gerald E is a declarant linked to Syros Pharmaceuticals, Inc. He has 4 filings in total, and the sampled recent filings cover the period from 2023-10-20 to 2024-11-20. The most common transaction nature is Levée d'options, and the buy and sell amounts shown for these recent filings are EUR 0 and EUR 0.